Newborn
Screening
Newborn Screening—also known as Neonatal Screening—involves testing newborns within the first days of life for inborn errors of metabolism and other serious disorders that are not visibly apparent at birth but can significantly affect a child’s physical, cognitive, and neurological development. Early detection of these conditions allows for timely interventions that can prevent long-term complications and improve health outcomes.
Trivitron offers a comprehensive range of Newborn Screening solutions, including modular and fully automated instrumentation, manual and automated equipment, and reagent kits. Through its diagnostics division, Labsystems Diagnostics Oy, Trivitron ranks as the second-largest provider of Newborn Screening technology globally, reinforcing its commitment to early detection and improved pediatric care.
Fluoro Enzymatic Assays
Fluoro Enzymatic Assays provide high-sensitivity detection of metabolic disorders using fluorescence-based measurement for early diagnosis...
Fluoro Enzymatic Immuno Assays
Labsystems Diagnostics introduced the first fluorometric microplate assay for phenylalanine to support newborn PKU diagnosis...
Newborn Screening Instruments
To run a successful and cost-effective newborn screening test, there is a requirement for all the instruments and reagents.
LC-MS/MS kits
Labsystems Diagnostics introduced world's first fluorometric microplate based assay for screening Phenyl Alanine in newborns to detect ...
Photometry
Triviton’s Newborn Screening is based on chemical enzyme assay and monoclonal antibody-based enzyme immunoassay using a microtitre plate...
Real Time PCR Kit
Real-Time PCR Kits enable rapid, accurate, and quantitative detection of genetic material, making them essential for diagnosing infectious diseases...